[HTML][HTML] Defining the role of the gut microbiome in the pathogenesis and treatment of lymphoid malignancies
S Upadhyay Banskota, SA Skupa, D El-Gamal… - International journal of …, 2023 - mdpi.com
The gut microbiome is increasingly being recognized as an important immunologic
environment, with direct links to the host immune system. The scale of the gut microbiome's …
environment, with direct links to the host immune system. The scale of the gut microbiome's …
[HTML][HTML] A systematic review and meta-analysis evaluating the impact of antibiotic use on the clinical outcomes of cancer patients treated with immune checkpoint …
A Crespin, C Le Bescop, J de Gunzburg, F Vitry… - Frontiers in …, 2023 - frontiersin.org
Background Immune checkpoint inhibitors (ICIs) have considerably improved patient
outcomes in various cancer types, but their efficacy remains poorly predictable among …
outcomes in various cancer types, but their efficacy remains poorly predictable among …
[HTML][HTML] The impact of antibiotic use on clinical features and survival outcomes of cancer patients treated with immune checkpoint inhibitors
J Zhou, G Huang, WC Wong, D Hu, J Zhu, R Li… - Frontiers in …, 2022 - frontiersin.org
Background Nowadays, immune checkpoint inhibitors (ICIs) have become one of the
essential immunotherapies for cancer patients. However, the impact of antibiotic (ATB) use …
essential immunotherapies for cancer patients. However, the impact of antibiotic (ATB) use …
Antibiotic use and survival of patients receiving pembrolizumab for chemotherapy-resistant metastatic urothelial carcinoma
Y Ishiyama, T Kondo, Y Nemoto, Y Kobari… - … Oncology: Seminars and …, 2021 - Elsevier
Objectives The use of antibiotics alters gut microbiota and has been reported to impact
outcomes in immune checkpoint inhibitor (ICI) treatment in various types of cancer. We …
outcomes in immune checkpoint inhibitor (ICI) treatment in various types of cancer. We …
[HTML][HTML] Recent advances in primary resistance mechanisms against immune checkpoint inhibitors
YZ Li, HM Zhang - Current Opinion in Oncology, 2022 - journals.lww.com
Recent advances in primary resistance mechanisms against imm... : Current Opinion in
Oncology Recent advances in primary resistance mechanisms against immune checkpoint …
Oncology Recent advances in primary resistance mechanisms against immune checkpoint …
Perturbation of the gut microbiome and association with outcomes following autologous stem cell transplantation in patients with multiple myeloma
C D'Angelo, S Sudakaran, F Asimakopoulos… - Leukemia & …, 2023 - Taylor & Francis
The gut microbiome is an important feature of host immunity with associations to
hematologic malignancies and cellular therapy. We evaluated the gut microbiome and …
hematologic malignancies and cellular therapy. We evaluated the gut microbiome and …
[HTML][HTML] Efficacy of immune checkpoint blockade and biomarkers of response in lymphoma: A narrative review
S Perdikis-Prati, S Sheikh, A Bouroumeau, N Lang - Biomedicines, 2023 - mdpi.com
Immune checkpoint blockade (ICB) has revolutionized the prognosis of several advanced-
stage solid tumors. However, its success has been far more limited in hematological …
stage solid tumors. However, its success has been far more limited in hematological …
Principles of Checkpoint Inhibition in Malignant Lymphoma
K Wudhikarn, SM Ansell - 2022 - Springer
Malignancies manipulate the physiologic immune system through various immune
checkpoint pathways to antagonize T cell activation and provide themselves an immune …
checkpoint pathways to antagonize T cell activation and provide themselves an immune …
Immune Checkpoint Blockade and Biomarkers of Response in Lymphoma: A Case-Illustrated Narrative Review
S Perdikis-Prati, S Sheikh, B Antonin, N Lang - 2023 - preprints.org
Immune checkpoint blockade (ICB) has revolutionized the prognosis of several advanced-
stage solid tumors. However, its success has been far more limited in hematological …
stage solid tumors. However, its success has been far more limited in hematological …